Established 5 years ago, our bulk drugs intermediate formulation unit in Mohali is now available for sale. The facility is situated on 2 acres of land with a built-up area of 40,400 sq ft. Our installed capacity is 190 KL/reactors, but we are currently operating at 10% production capacity. Our API product list includes Aceclofenac IP, Ascorbic Acid IP, Clarithromycin, Diclofenac IP, 2 Ethyl Sodium Hexonate, Pantoprazole IP, and Sodium Citrate IP, among others. Our intermediates include Calcium Phosphoryl, Choline Chloride (CPCC, intermediate of Citicoline Sodium), OPA (Ortho Phenoxy Aniline), and OPMSA (Ortho Phenoxy Methane Sulfonilide), among others. We are dedicated to providing high-quality, cost-effective products and have established a portfolio of affordable medicines accessible to all. This is an excellent opportunity for investors looking to acquire a well-equipped pharmaceutical manufacturing unit with significant growth potential.
2020
55
Running
No
Owned
N.A
N.A
N.A
Yes we have some competition
Our API product list includes Aceclofenac IP, Ascorbic Acid IP, Clarithromycin, Diclofenac IP, 2 Ethyl Sodium Hexonate, Pantoprazole IP, and Sodium Citrate IP, among others. Our intermediates include Calcium Phosphoryl, Choline Chloride (CPCC, intermediate of Citicoline Sodium), OPA (Ortho Phenoxy Aniline), and OPMSA (Ortho Phenoxy Methane Sulfonilide)
Growth rate is high
Working capital shortage
| Asking Price | 32 Crs |
| Turnover | 10 Crs |
| Legal Entity | Private Limited |
| Category | Pharmaceutical Industry |
| Sub Category | API Bulk Drugs |
| Business Listed By | Business Owner |
Asking Price :- Rs. 3.5 Crs
Investment :- Rs. 1 Crs
Asking Price :- Rs. 1.5 Crs
Asking Price :- Rs. 10 Lacs
Asking Price :- Rs. 15 Lacs
Asking Price :- Rs. 200 Crs
